Related Experiment Video
Updated: Jan 10, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
First reported allergen immunotherapy anaphylaxis treated with neffy nasal spray: A case series
Jake Rosenblum1, Gregory Puglisi1, Joseph Grillo1
1Mid Island Allergy Group, Plainview, NY.
None:
The neffy intranasal epinephrine delivery system was recently approved by the US Food and Drug Administration; however, published information on its real-world use is limited. Immunotherapy patients reacting in our clinic experienced prompt symptom resolution with neffy, highlighting its viability as an alternative to intramuscular injection in managing anaphylactic reactions.
Related Concept Videos
Allergic Reactions
Allergic Drug Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...

